| [1] |
Kitahara CM，Sosa JA.The changing incidence of thyroid cancer[J].Nat Rev Endocrinol，2016，12（11）：646.
|
| [2] |
Wiltshire JJ，Drake TM，Uttley L，et al.Systematic review of trends in the incidence rates of thyroid cancer[J].Thyroid，2016，26（11）：1541-1552.
|
| [3] |
Lim H，Devesa SS，Sosa JA，et al.Trends in thyroid cancer incidence and mortality in the United States，1974-2013[J].JAMA，2017，317（13）：1338-1348.
|
| [4] |
Oda H，Miyauchi A，Ito Y，et al.Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery[J].Thyroid，2016，26（1）：150-155.
|
| [5] |
Li D，Gao M，Li X，et al.Molecular aberrance in papillary thyroid microcarcinoma bearing high aggressiveness：identifying a “tibetan mastiff dog” from puppies[J].J Cell Biochem，2016，117（7）：1491-1496.
|
| [6] |
Leboulleux S，Tuttle RM，Pacini F，et al.Papillary thyroid microcarcinoma：time to shift from surgery to active surveillance？[J].Lancet Diabetes Endocrinol，2016，4（11）：933-942.
|
| [7] |
Lee J，Soh EY.Current guidelines for fine needle aspiration of thyroid nodules[J].Korean J Endocrine Surg，2015，15（1）：1-5.
|
| [8] |
Zevallos JP，Hartman CM，Kramer JR，et al.Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration：a study of the Veterans Affairs health care system[J].Cancer，2015，121（5）：741-746.
|
| [9] |
Eszlinger M，Lau L，Ghaznavi S，et al.Molecular profiling of thyroid nodule fine-needle aspiration cytology[J].Nat Rev Endocrinol，2017，13（7）：415.
|
| [10] |
戎荣，吴妍，姚青，等.甲状腺细针穿刺检查2043例细胞病理学分析[J].中华病理学杂志，2016，45（6）：368-371.
|
| [11] |
Lee YH，Baek JH，Jung SL，et al.Ultrasound-guided fine needle aspiration of thyroid nodules：a consensus statement by the Korean Society of Thyroid Radiology[J].Korean J Radiol，2015，16（2）：391-401.
|
| [14] |
Cabanillas ME，Mcfadden DG，Durante C.Thyroid cancer[J].The Lancet，2016，388（10061）：2783-2795.
|
| [12] |
Shao H，Yu X，Wang C，et al.Midkine expression is associated with clinicopathological features and BRAF mutation in papillary thyroid cancer[J].Endocrine，2014，46（2）：285-291.
|
| [13] |
Choi YW，Kim YH，Lee J，et al.Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma[J].Human pathology，2015，46（10）：1557-1565.
|
| [15] |
Chiosea S，Asa SL，Berman MA，et al.Template for reporting results of biomarker testing of specimens from patients with thyroid carcinoma[J].Arch Pathol Lab Med，2016，141（4）：559-563.
|
| [16] |
Muramatsu T.Structure and function of midkine as the basis of its pharmacological effects[J].Br J Pharmacol，2014，171（4）：814-826.
|
| [17] |
Jones DR.Measuring midkine：the utility of midkine as a biomarker in cancer and other diseases[J].Br J Pharmacol，2014，171（12）：2925-2939.
|
| [18] |
Maeda S，Shinchi H，Kurahara H，et al.Clinical significance of Midkine expression in pancreatic head carcinoma[J].Br J Cancer，2007，97（3）：405-408.
|
| [19] |
Zhao ZQ，Yang S，Lu HS.Expression of Midkine and vascular endothelial growth factor in gastric cancer and the association of high levels with poor prognosis and survival[J].Mol Med Rep，2012，5（2）：415-419.
|
| [20] |
Jham BC，Costa NL，Silva JM，et al.Midkine expression in oral squamous cell carcinoma and leukoplakia[J].J Oral Pathol Med，2012，41（1）：21-26.
|
